Table 4. Diagnostic performance of US-guided PCNB.
Biopsy result | Final result | Total | |
---|---|---|---|
Malignancy | Benign | ||
Malignancy | 453 (79.2%) | 0 | 453 |
Benign | 55 (9.6%) | 64 (11.2%) | 119 |
Total | 508 | 64 | 572 |
Non-diagnostic results of US-guided PCNB were considered as false positives, resulting in discrepancy of malignancy rate of final diagnosis. US, ultrasound; PCNB, percutaneous core needle biopsy.